Benzinga··NaSciSparc's NeuroThera Labs to Acquire Majority Stake in Quantum Clinical Trials Pioneer
SciSparc's NeuroThera Labs acquires 54% of quantum clinical trials company CliniQuantum for $9.46M in stock plus $2.5M earn-out, closing by March 2026.
SPRCacquisitionclinical trials